SaudiBio

SAUDIBIO

THE FIRST & ONLY BIOTECHNOLOGY MANUFACTURING FACILITY IN SAUDI ARABIA

SAUDIBIO

"THE FIRST & ONLY BIOTECHNOLOGY MANUFACTURING FACILITY IN SAUDI ARABIA"

chairman new1
Dr. khaled Almosa

Working together towards drug security

SAUDIBIO is a Joint Stock company duly incorporated in the Kingdom of Saudi Arabia. It is the owner of The First and Only multipurpose sterile fill and finish facility for biopharmaceutical products including Recombinant Human Insulin and Biosimilars products in Saudi Arabia.

SAUDIBIO was founded by DR.KHALED ALMOSA, Health Care Management Consultant. Dr.Khaled is a member of KSA supreme committee for Research, Development & Innovation, Council of Economics & Development Affairs, Council of Ministers. SAUDIBIO is chaired by H.E.Dr.Hussein Aljezairy, Ex-Minister of health, Saudi Arabia and Ex-Regional director for the Eastern Mediterranean Region, World Health Organization.

LIFERA ACQUIRES SAUDIBIO TO SCALE UP LOCAL MANUFACTURING OF INSULIN IN SAUDI ARABIA

• Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF), acquires a 70% stake in Saudi Biotechnology Manufacturing Co (‘SaudiBio’).
Read more..

What we do

Utilizing advanced technologies to redefine medicine

Modular Aseptic Solutions (MAS) are utilized for fill finish of liquid solutions and lyophilization. Filling in Pre-sterilized containers is one of our primary advantage for biologicals.

As industry leaders, we are focused on a new era of development and growth powered by the Vision 2030 of Saudi Arabia

Our services

Insight into how it works when partnering with us

1

SAUDIBIO is committed to participate with government strategy towards drug security by making essential drugs locally available.

2

Localizing - Many new local regulations were issued to support and favor local products in all governmental tenders.

3

SAUDIBIO is the First & Only GMP certified biotech manufacturing facility in the Kingdom of Saudi Arabia

4

Our capabilities in the region - beyond manufacturing- include registration of products at regulatory authorities and generating ethical sales across MENA.

Our Business Partners

Strength through our unique diversity

NOVO NORDISK is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

NOVO NORDISK and SAUDIBIO have signed license, supply and quality agreements for local manufacturing of Insulin and Haemophilia products.

H.E Saudi Minister of Industry & Mineral resources launches the first Insulin batch (SaudiBio - Novo Nordisk)

vision2030

Benefiting the community - locally and globally

We adopt the highest quality standards to deliver reliable service & high-quality products from the GMP Certified production facility.
We care for the community we live and work in.

vision2030
supporters

Interested in finding out more? Get in touch.